RT Journal Article
SR Electronic
T1 1073 A phase 1, first-in-human, open-label study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of PRJ1–3024in subjects with advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1182
OP A1182
DO 10.1136/jitc-2023-SITC2023.1073
VO 11
IS Suppl 1
A1 Starodub, Alexander
A1 Henry, Jason
A1 Vandross, Andrae
A1 Perez, Cesar
A1 Spira, Alexander I
A1 Xu, Yang
A1 Li, Yuping
A1 Liao, Xuebin
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1182.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.